Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 16;27(24):8970.
doi: 10.3390/molecules27248970.

Effect of Esculetin on Tert-Butyl Hydroperoxide-Induced Oxidative Injury in Retinal Pigment Epithelial Cells In Vitro

Affiliations

Effect of Esculetin on Tert-Butyl Hydroperoxide-Induced Oxidative Injury in Retinal Pigment Epithelial Cells In Vitro

Woo Kwon Jung et al. Molecules. .

Abstract

Esculetin is a coumarin-derived compound with antioxidant and anti-inflammatory properties. The current study aims to evaluate the therapeutic implications of esculetin on retinal dysfunction and uncover the underlying mechanisms. Tert-butyl hydroperoxide (t-BHP) at a concentration of 300 μM was used to induce oxidative stress in human retinal pigment epithelial cell line (ARPE-19) cells. Esculetin at concentrations below 250 μM did not cause cytotoxicity to ARPE-19 cells. Cell viability analysis confirmed that t-BHP induced oxidative injury of ARPE-19 cells. However, ARPE-19 cells were protected from t-BHP-induced oxidative injury by esculetin in a concentration-dependent manner. As a result of the TUNEL assay to confirm apoptosis, esculetin treatment reduced the number of TUNEL-positive cells. Esculetin down-regulated the expression levels of Bax, Caspase-3, and PARP and up-regulated the expression level of Bcl2. Collectively, this study demonstrates that esculetin exerts potent antioxidant properties in ARPE-19 cells, inhibiting t-BHP-induced apoptosis under the regulation of apoptotic factors.

Keywords: age-related macular degeneration; apoptosis; esculetin; oxidative stress; retinal pigment epithelial cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Effect of esculetin on ARPE-19 cell injury. Cell viability of ARPE-19 cells exposed to different concentrations of esculetin (A), t-BHP (B), and t-BHP with esculetin (C) for 24 h. (D) Changes in ROS levels in ARPE-19 cells exposed to t-BHP with esculetin for 24 h were detected using DCFH-DA dye. (E,F) The intracellular levels of ROS were measured using CellROX green reagent. Scale bar = 25 μm. The values in the bar graphs represent the means ± SEM, n = 5. * p < 0.05 vs. control group, # p < 0.05 vs. t-BHP-treated group.
Figure 1
Figure 1
Effect of esculetin on ARPE-19 cell injury. Cell viability of ARPE-19 cells exposed to different concentrations of esculetin (A), t-BHP (B), and t-BHP with esculetin (C) for 24 h. (D) Changes in ROS levels in ARPE-19 cells exposed to t-BHP with esculetin for 24 h were detected using DCFH-DA dye. (E,F) The intracellular levels of ROS were measured using CellROX green reagent. Scale bar = 25 μm. The values in the bar graphs represent the means ± SEM, n = 5. * p < 0.05 vs. control group, # p < 0.05 vs. t-BHP-treated group.
Figure 2
Figure 2
Effect of esculetin on t-BHP-induced apoptosis in ARPE-19 cells. (A) Apoptosis of ARPE-19 cells exposed to t-BHP with esculetin for 24 h was detected using TUNEL staining. ×100 magnification. Scale bar = 50 μm. (B) The values in the bar graphs represent the means ± SEM, n = 5. * p < 0.05 vs. control group, # p < 0.05 vs. t-BHP-treated group.
Figure 2
Figure 2
Effect of esculetin on t-BHP-induced apoptosis in ARPE-19 cells. (A) Apoptosis of ARPE-19 cells exposed to t-BHP with esculetin for 24 h was detected using TUNEL staining. ×100 magnification. Scale bar = 50 μm. (B) The values in the bar graphs represent the means ± SEM, n = 5. * p < 0.05 vs. control group, # p < 0.05 vs. t-BHP-treated group.
Figure 3
Figure 3
Effect of esculetin on apoptosis-related signaling pathways in ARPE-19 cells. (A) Apoptosis-related protein assay. (B) The values in the bar graphs represent the means ± SEM, n = 4. * p < 0.05 vs. control group, # p < 0.05 vs. t-BHP treated group.
Figure 3
Figure 3
Effect of esculetin on apoptosis-related signaling pathways in ARPE-19 cells. (A) Apoptosis-related protein assay. (B) The values in the bar graphs represent the means ± SEM, n = 4. * p < 0.05 vs. control group, # p < 0.05 vs. t-BHP treated group.
Figure 4
Figure 4
Effect of esculetin on the expression of apoptosis-related proteins in ARPE-19 cells. (A) The protein expression levels of Bax, bcl-2, cleaved caspase-3, and cleaved PARP. (B) The values in the bar graphs represent the means ± SEM, n = 4. * p < 0.05 vs. control group, # p < 0.05 vs. t-BHP treated group.
Figure 5
Figure 5
Effect of esculetin on the expression of apoptosis-related mRNA in ARPE-19 cells. The levels of mRNA expression of Bax, bcl-2, caspase-3 and PARP. The values in the bar graphs represent the means ± SEM, n = 4. * p < 0.05 vs. control group, # p < 0.05 vs. t-BHP treated group.

Similar articles

Cited by

References

    1. Klein R., Klein B.E. The prevalence of age-related eye diseases and visual impairment in aging: Current estimates. Investig. Ophthalmol. Vis. Sci. 2013;54:ORSF5–ORSF13. doi: 10.1167/iovs.13-12789. - DOI - PMC - PubMed
    1. Zarbin M.A., Casaroli-Marano R.P., Rosenfeld P.J. Age-related macular degeneration: Clinical findings, histopathology and imaging techniques. Cell-Based Ther. Retin. Degener. Dis. 2014;53:1–32. - PubMed
    1. Ishikawa M., Jin D., Sawada Y., Abe S., Yoshitomi T. Future therapies of wet age-related macular degeneration. J. Ophthalmol. 2015;2015:138070. doi: 10.1155/2015/138070. - DOI - PMC - PubMed
    1. Eyetech Study G. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: Phase II study results. Ophthalmology. 2003;110:979–986. - PubMed
    1. Campa C., Harding S.P. Anti-VEGF compounds in the treatment of neovascular age related macular degeneration. Curr. Drug Targets. 2011;12:173–181. doi: 10.2174/138945011794182674. - DOI - PubMed